A series of vitro experiments revealed that SRGN expression upregulated ABCG2, BMI1, and Nanog, enhancing the sphere-forming ability of HCC cells and increasing the population of cells with cancer stem cell-like characteristics. This evidence concerns the gene NANOG and hepatocellular carcinoma.